Understanding how certain enzymes help build bacterial cell walls
Project 1: Structure, function, and inhibition of SEDS-family peptidoglycan polymerases
This study is looking at certain enzymes that help bacteria build their cell walls, with the goal of finding new ways to fight bacterial infections, which could lead to better antibiotics for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11112644 on NIH RePORTER |
What this research studies
This research investigates the structure and function of specific enzymes known as SEDS-family peptidoglycan polymerases, which play a crucial role in the formation of bacterial cell walls. By examining how these enzymes work and how they can be inhibited, the research aims to develop new strategies for combating bacterial infections. The approach involves detailed biochemical analysis and structural biology techniques to understand the mechanisms at play. Patients may benefit from potential new treatments that target these enzymes, leading to more effective antibiotics.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections, particularly those caused by antibiotic-resistant bacteria.
Not a fit: Patients with viral infections or non-bacterial conditions are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel antibiotics that are more effective against resistant bacterial strains.
How similar studies have performed: Other research has shown promise in targeting bacterial cell wall synthesis as a strategy for developing new antibiotics, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Kruse, Andrew — Harvard Medical School
- Study coordinator: Kruse, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.